Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 3Carcinoma, Renal Cell 3Leiomyosarcoma 2Solid Neoplasm 1Sarcoma, Synovial 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Refractory or Recurrent Solid Tumor 1Recurrence 1Perivascular Epithelioid Cell Neoplasms 1Neurofibrosarcoma 1Neuroendocrine Tumors 1Nerve Sheath Neoplasms 1Liposarcoma 1Kidney Neoplasms 1Histiocytoma, Malignant Fibrous 1Histiocytoma, Angiomatoid Fibrous 1Granuloma, Plasma Cell 1Glioblastoma 1Fibrosarcoma 1Dermatofibrosarcoma 1Chondrosarcoma, Mesenchymal 1Chondrosarcoma, Extraskeletal Myxoid 1Carcinosarcoma 1

Interventions

Specimen Handling 6Magnetic Resonance Spectroscopy 5Biopsy 4pembrolizumab 2olaparib 2durvalumab 2ceralasertib 2Nivolumab 2trastuzumab deruxtecan 1pelcitoclax 1pazopanib 1cobimetinib 1cediranib 1capivasertib 1cabozantinib 1X-Rays 1Taxes 1Radiation 1Phantoms, Imaging 1Paclitaxel 1Ipilimumab 1Immunoglobulin G 1Gemcitabine 1Fluid Therapy 1Disulfides 1Congresses as Topic 1Carboplatin 1CTLA-4 Antigen 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinosarcoma × pazopanib × Clear all
NCT02203760 2024-11-15

PazoDoble

North Eastern German Society of Gynaecological Oncology

Phase 2 Active not recruiting
58 enrolled
Sarcoma

Carcinosarcoma, Leiomyosarcoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡